Description

Laktomun Sachet 1.5 g. №14

Ingredients:

Each sachet contains: Lactulose 1.5 g.

Dosage:

Adults and children over 14 years: 1-3 sachets daily, or as directed by a healthcare professional.

Indications:

Laktomun Sachet 1.5 g. №14 is indicated for the treatment of constipation and hepatic encephalopathy.

Contraindications:

Do not use Laktomun Sachet 1.5 g. №14 if you are sensitive to any of the ingredients.

Directions:

Dissolve the contents of one sachet in water and drink. It is important to follow the dosage instructions provided by your healthcare provider.

Scientific Evidence:

Lactulose, the active ingredient in Laktomun Sachet 1.5 g. №14, is a synthetic disaccharide that is not absorbed in the small intestine but is fermented by gut bacteria in the colon. This fermentation process leads to the production of short-chain fatty acids, which acidify the colonic contents, promoting the retention of ammonia in the colon and reducing its absorption. This mechanism is particularly beneficial in the management of hepatic encephalopathy.

Additional Information:

Laktomun Sachet 1.5 g. №14 is a well-tolerated and effective treatment option for constipation and hepatic encephalopathy. It is supported by clinical trials demonstrating its efficacy in improving bowel function and reducing ammonia levels in patients with liver disease. Consult your healthcare provider for personalized recommendations and dosing instructions.

Research studies have shown that the use of lactulose, such as in Laktomun Sachet 1.5 g. №14, can significantly reduce the risk of hepatic encephalopathy recurrence in patients with cirrhosis. Additionally, its laxative effect makes it a valuable option for managing constipation in various patient populations.

The pharmacological action of Laktomun Sachet 1.5 g. №14 involves altering the colonic environment to promote the excretion of ammonia, a key factor in the pathogenesis of hepatic encephalopathy. By modulating the gut microbiota and acidifying the colon, lactulose helps improve cognitive function and overall outcomes in patients with liver dysfunction.